Peripheral neuropathy caused by proteolipid protein gene mutations
Related Experiment Video
Updated: Oct 18, 2026

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
J Y Garbern1, F Cambi, R Lewis
1Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. j_garbern@wayne.edu
Abstract:
Pelizaeus-Merzbacher disease (PMD) is a dysmyelinating disorder of the central nervous system typically caused by duplications or missense mutations of the proteolipid protein (PLP) gene. Most investigators have found that peripheral nerve function and structure is normal in PMD patients. We have found that null mutations of the PLP gene cause demyelinating peripheral neuropathy, whereas duplications and a proline 14 to leucine mutation do not affect nerve function. A family with a nonsense mutation at position 144, which affects only PLP but not the alternatively spliced gene product DM20, has a very mild syndrome, including normal peripheral nerve function. Our findings suggest that DM20 alone is sufficient to maintain normal nerve function and that there may be domains of PLP/DM20 that have a relatively more active role in the peripheral nervous system compared with that in the central nervous system.
Related Concept Videos
Diabetic Neuropathy
Parkinson Disease ll: Pathophysiology
Lysosomal Hydrolases
Alzheimer Disease l: Introduction
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
